Opioid use treatment
Pro Research Analysisby 
Searched over 200M research papers
Effective Treatments for Opioid Use Disorder (OUD)
Medication-Assisted Treatment (MAT) for Opioid Use Disorder
Methadone, Buprenorphine, and Naltrexone
Medication-assisted treatment (MAT) is a cornerstone in managing opioid use disorder (OUD). The primary medications used are methadone, buprenorphine, and naltrexone. Methadone, a full opioid agonist, and buprenorphine, a partial agonist, work by suppressing withdrawal symptoms and reducing the effects of other opioids. Naltrexone, an opioid antagonist, blocks the euphoric effects of opioids Bell2020Connery2015McCarty2017. Methadone has the strongest evidence for effectiveness, particularly when treatment duration is extended, allowing for the restoration of social connections and better outcomes .
Challenges and Innovations in MAT
Despite the effectiveness of these medications, treatment adherence is often poor, and relapse rates are high. There is also a risk of medication diversion and misuse, particularly with methadone and buprenorphine. To address these issues, new depot and implant formulations of buprenorphine and naltrexone have been developed, which improve safety and adherence Bell2020Connery2015. Additionally, supervised injectable opioid treatment and take-home naloxone programs are emerging as strategies to minimize overdose risks .
Behavioral Interventions and Integrated Care Models
Mindfulness-Oriented Recovery Enhancement (MORE)
Behavioral interventions like Mindfulness-Oriented Recovery Enhancement (MORE) have shown promise in treating co-occurring chronic pain and opioid misuse. In a randomized controlled trial, MORE participants reported significant reductions in pain severity, stress, and desire for opioids, and were more likely to no longer meet criteria for OUD immediately following treatment . However, these effects were not sustained at follow-up, indicating the need for ongoing support.
Integration into Primary Care
Integrating OUD treatment into primary care settings has been shown to be effective and cost-efficient. Primary care-based models, such as office-based opioid treatment (OBOT) with buprenorphine, have demonstrated similar retention and opioid use outcomes to traditional methadone treatment programs Korthuis2016Buresh2021. This approach is particularly advantageous for patients already engaged in primary care and offers an alternative for those who cannot access methadone treatment programs .
Policy and Access to Treatment
Hospital-Based Interventions
Hospitalizations for other medical conditions provide a unique opportunity to initiate OUD treatment. International guidelines recommend the use of methadone and buprenorphine during such hospitalizations, but inconsistent policies and interpretations of regulations often limit their use . Standardizing these practices could engage a vulnerable patient population in treatment .
Expanding Access and Reducing Stigma
Expanding access to MAT and reducing stigma are critical for addressing the opioid crisis. Despite the availability of effective medications, they are underused, and the risk of relapse remains high. Strategies to expand medication use and improve treatment retention include greater involvement of healthcare professionals and addressing comorbidities such as depression and suicidality, which contribute to relapse and overdose fatalities .
Conclusion
Effective treatment of opioid use disorder requires a multifaceted approach that includes medication-assisted treatment, behavioral interventions, and integration into primary care settings. Expanding access to these treatments and reducing stigma are essential for improving outcomes and preventing fatalities. Ongoing research and policy changes are needed to address the challenges and optimize care for individuals with OUD.
Sources and full results
Most relevant research papers on this topic